1 Min Read
* PLEDPHARMA RECEIVES EUROPEAN APPROVAL OF THE COMPOSITION OF MATTER PATENT FOR PLEDOX® AND ALADOTE®
* EXPIRY DATE FOR PATENT IS DECEMBER, 2032. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.